{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:58:15Z","timestamp":1794959895821,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["CLIN2-14315"],"award-info":[{"award-number":["CLIN2-14315"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anonymous Philanthropic Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41591-025-03817-1","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T09:02:55Z","timestamp":1753174975000},"page":"3183-3190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Irradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trial"],"prefix":"10.1038","volume":"31","author":[{"given":"Rajni","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bertaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-7052","authenticated-orcid":false,"given":"Charmaine","family":"Soco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janel R.","family":"Long-Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopin","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Kunte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsie","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Willner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Krampf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rofida","family":"Nofal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Barbarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5188-9298","authenticated-orcid":false,"given":"Maite","family":"Van Hentenryck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Walck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Scheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda J.","family":"Perriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Bouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Istomina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hena Naz","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna F.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-9643","authenticated-orcid":false,"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3246-4726","authenticated-orcid":false,"given":"Judith A.","family":"Shizuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy W.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robertson","family":"Parkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1636-1495","authenticated-orcid":false,"given":"Maria Grazia","family":"Roncarolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3850-4648","authenticated-orcid":false,"given":"Matthew","family":"Porteus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2909-2669","authenticated-orcid":false,"given":"Agnieszka","family":"Czechowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"3817_CR1","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/S2352-3026(22)00032-1","volume":"9","author":"C Bonfim","year":"2022","unstructured":"Bonfim, C. et al. Transplantation for Fanconi anaemia: lessons learned from Brazil. Lancet Haematol. 9, e228\u2013e236 (2022).","journal-title":"Lancet Haematol."},{"key":"3817_CR2","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1182\/blood-2018-06-858159","volume":"133","author":"W Pang","year":"2019","unstructured":"Pang, W. et al. Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice. Blood 133, 2069\u20132078 (2019).","journal-title":"Blood"},{"key":"3817_CR3","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1182\/blood-2018-06-853879","volume":"133","author":"HS Kwon","year":"2019","unstructured":"Kwon, H. S. et al. Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice. Blood 133, 2104\u20132108 (2019).","journal-title":"Blood"},{"key":"3817_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1182\/blood-2021-153074","volume":"138","author":"R Agarwal","year":"2021","unstructured":"Agarwal, R. et al. JSP191 as a single-agent conditioning regimen results in successful engraftment, donor myeloid chimerism, and production of donor derived na\u00efve lymphocytes in patients with severe combined immunodeficiency (SCID). Blood 138, 554 (2021).","journal-title":"Blood"},{"key":"3817_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","volume":"124","author":"A Bertaina","year":"2014","unstructured":"Bertaina, A. et al. HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B-cells in children with non-malignant disorders. Blood 124, 822\u2013826 (2014).","journal-title":"Blood"},{"key":"3817_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","volume":"130","author":"F Locatelli","year":"2017","unstructured":"Locatelli, F. et al. Outcome of children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion. Blood 130, 677\u2013685 (2017).","journal-title":"Blood"},{"key":"3817_CR7","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1182\/blood-2018-07-861575","volume":"132","author":"A Bertaina","year":"2018","unstructured":"Bertaina, A. et al. Unrelated donor vs HLA-haploidentical alpha\/beta T-cell- and B-cell-depleted HSCT in children with acute leukemia. Blood 132, 2594\u20132607 (2018).","journal-title":"Blood"},{"key":"3817_CR8","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.1200\/JCO.2021.39.15_suppl.7035","volume":"39","author":"LS Muffly","year":"2021","unstructured":"Muffly, L. S. et al. Early results of phase 1 study of JSP191, an anti-CD117 monoclonal antibody, with non-myeloablative conditioning in older adults with MRD-positive MDS\/AML undergoing allogeneic hematopoietic cell transplantation. J. Clin. Oncol. 39, 7035 (2021).","journal-title":"J. Clin. Oncol."},{"key":"3817_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","volume":"101","author":"DI Kutler","year":"2003","unstructured":"Kutler, D. I. et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101, 1249\u20131256 (2003).","journal-title":"Blood"},{"key":"3817_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/MPH.0000000000000374","volume":"37","author":"A Schifferli","year":"2015","unstructured":"Schifferli, A. & K\u00fchne, T. Fanconi anemia: overview of the disease and the role of hematopoietic transplantation. J. Pediatr. Hematol. Oncol. 37, 335\u2013343 (2015).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"3817_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1182\/asheducation-2011.1.492","volume":"2011","author":"J Soulier","year":"2011","unstructured":"Soulier, J. Fanconi anemia. Hematol. Am. Soc. Hematol. Educ. Program 2011, 492\u2013497 (2011).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"3817_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tig.2017.11.006","volume":"34","author":"R Che","year":"2018","unstructured":"Che, R., Zhang, J., Nepal, M., Han, B. & Fei, P. Multifaceted Fanconi anemia signaling. Trends Genet. 34, 171\u2013183 (2018).","journal-title":"Trends Genet."},{"key":"3817_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.blre.2016.10.002","volume":"31","author":"NE Mamrak","year":"2017","unstructured":"Mamrak, N. E., Shimamura, A. & Howlett, N. G. Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia. Blood Rev. 31, 93\u201399 (2017).","journal-title":"Blood Rev."},{"key":"3817_CR14","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1182\/blood-2021-147071","volume":"138","author":"A Czechowicz","year":"2021","unstructured":"Czechowicz, A. et al. Gene therapy for Fanconi anemia [group A]: interim results of RP-L102 clinical trials. Blood 138, 3968\u20133969 (2021).","journal-title":"Blood"},{"key":"3817_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17474086.2016.1268048","volume":"10","author":"CL Ebens","year":"2017","unstructured":"Ebens, C. L., MacMillan, M. L. & Wagner, J. E. Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations. Expert Rev. Hematol. 10, 81\u201397 (2017).","journal-title":"Expert Rev. Hematol."},{"key":"3817_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1365-2141.2000.01955.x","volume":"109","author":"ML MacMillan","year":"2000","unstructured":"MacMillan, M. L. et al. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br. J. Haematol. 109, 121\u2013129 (2000).","journal-title":"Br. J. Haematol."},{"key":"3817_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3324\/haematol.2017.178111","volume":"103","author":"BP Alter","year":"2018","unstructured":"Alter, B. P., Giri, N., Savage, S. A. & Rosenberg, P. S. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica 103, 30\u201339 (2018).","journal-title":"Haematologica"},{"key":"3817_CR18","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood.V112.11.2998.2998","volume":"112","author":"L MacMillan","year":"2008","unstructured":"MacMillan, L. et al. Alternate Donor HCT for Fanconi anemia (FA): results of a total body irradiation (TBI) dose de-escalation study. Blood 112, 2998 (2008).","journal-title":"Blood"},{"key":"3817_CR19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/bloodadvances.2020003707","volume":"5","author":"L Strocchio","year":"2021","unstructured":"Strocchio, L. et al. HLA-haploidentical TCR\u03b1\u03b2+\/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia. Blood Adv. 5, 1333\u20131339 (2021).","journal-title":"Blood Adv."},{"key":"3817_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1080\/14653240701644000","volume":"9","author":"S Chaleff","year":"2007","unstructured":"Chaleff, S. et al. A large-scale method for the selective depletion of \u03b1\u03b2 T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy 9, 746\u2013754 (2007).","journal-title":"Cytotherapy"},{"key":"3817_CR21","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jcyt.2013.05.014","volume":"15","author":"M Schumm","year":"2013","unstructured":"Schumm, M. et al. Depletion of T-cell receptor alpha\/beta and CD19 positive cells from apheresis products with the CliniMACS device. Cytotherapy 15, 1253\u20131258 (2013).","journal-title":"Cytotherapy"},{"key":"3817_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40262-014-0214-6","volume":"54","author":"R Admiraal","year":"2015","unstructured":"Admiraal, R. et al. Population pharmacokinetic modeling of Thymoglobulin in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing. Clin. Pharmacokinet. 54, 435\u2013446 (2015).","journal-title":"Clin. Pharmacokinet."},{"key":"3817_CR23","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","volume":"2","author":"R Admiraal","year":"2015","unstructured":"Admiraal, R. et al. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol. 2, e194\u2013e203 (2015).","journal-title":"Lancet Haematol."},{"key":"3817_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1182\/bloodadvances.2021005584","volume":"6","author":"M Lakkaraja","year":"2022","unstructured":"Lakkaraja, M. et al. Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation. Blood Adv. 6, 1054\u20131063 (2022).","journal-title":"Blood Adv."},{"key":"3817_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.bbmt.2017.06.021","volume":"23","author":"V Ivaturi","year":"2017","unstructured":"Ivaturi, V. et al. Pharmacokinetics and model-based dosing to optimize fludarabine therapy in pediatric hematopoietic cell transplant recipients. Biol. Blood Marrow Transpl. 23, 1701\u20131713 (2017).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"3817_CR26","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1182\/bloodadvances.2018029421","volume":"3","author":"JB Langenhorst","year":"2019","unstructured":"Langenhorst, J. B. et al. Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes. Blood Adv. 3, 2179\u20132187 (2019).","journal-title":"Blood Adv."},{"key":"3817_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/JBM.S190327","volume":"10","author":"W Barcellini","year":"2019","unstructured":"Barcellini, W., Fattizzo, B. & Zaninoni, A. Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. J. Blood Med 10, 265\u2013278 (2019).","journal-title":"J. Blood Med"},{"key":"3817_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1182\/blood-2004-04-1652","volume":"105","author":"PS Rosenberg","year":"2005","unstructured":"Rosenberg, P. S., Soci\u00e9, G., Alter, B. P. & Gluckman, E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105, 67\u201373 (2005).","journal-title":"Blood"},{"key":"3817_CR29","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1182\/blood-2016-09-743112","volume":"129","author":"PA Mehta","year":"2017","unstructured":"Mehta, P. A. et al. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study. Blood 129, 2308\u20132315 (2017).","journal-title":"Blood"},{"key":"3817_CR30","doi-asserted-by":"publisher","first-page":"eaax8863","DOI":"10.1126\/scitranslmed.aax8863","volume":"12","author":"S Busque","year":"2020","unstructured":"Busque, S. et al. Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal. Sci. Transl. Med. 12, eaax8863 (2020).","journal-title":"Sci. Transl. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03817-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03817-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03817-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:10:00Z","timestamp":1788516600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03817-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03817-1","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B. is a consultant and received honoraria from Miltenyi and Neovii. L.H. is a member of an advisory committee of and received honoraria from Sobi. J.J.B. received honoraria from Advanced Clinical and is a consultant for and received honoraria from Immusoft, Sanofi, Sobi and SmartImmune. J.A.S. and W.W.P. are consultants and current equity holders for Jasper Therapeutics. M.G.R. is a current equity holder for Graphite Biologics, TR1X, Atara and Kamau Therapeutics and a member of their boards of directors or advisory committees. M.P. is a current equity holder for Graphite Biologics, Allogene Therapeutics and Alaunos Therapeutics and a member of their boards of directors or advisory committees; he is also a current equity holder of Kamau Therapeutics and CRISPR Tx. A.C. is a current equity holder of Beam Therapeutics, Dianthus Therapeutics and Editas Medicines; a consultant and\/or current equity holder for Fulcrum Therapeutics, GV, Land Medicine and Kyowa Kirin; holds patents and royalties for Inograft Biotherapeutics and is a current equity holder and member of their advisory committee; holds patents and royalties for and research funding from Jasper Therapeutics; holds patents and royalties for Magenta Therapeutics; is a current equity holder for and a member of advisory committees for Permanence Bio and Prime Medicines; has research funding from and is a consultant for Rocket Pharma; and is a current equity holder for Spotlight Therapeutics and Teiko Bio. In addition, A.C. and other authors are inventors on various patents related to antibody-based conditioning. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}